Thermo Fisher selling microbiology business to Astorg for over $1bn
Listed US-based supplier of scientific instrumentation, reagents, consumables, and software Thermo Fisher Scientific has agreed to divest its global microbiology business to the European private equity firm Astorg. The transaction, valued at approximately $1.075bn, is slated to close in the second half of 2026 subject to customary regulatory approvals. For operators in the clinical and laboratory space, the transition marks…